RT-qPCR demonstrated that ELF4 was effectively knockdown by si-ELF4-1 in U87MG and U251 glioma cells, compared with the mRNA expression level of ELF4 in the si-control (si-CTL) group (Fig. 9C). This evidence concerns the gene ELF4 and central nervous system cancer.